Rafael C. Chelucci
Sao Carlos, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Identification of a Benzenesulfonylpiperazine Derivative With In Vivo Efficacy Against Visceral Leishmaniasis.
Journal: Chemical biology & drug design
Published: April 10, 2026
Multiscale-Aware Graph Embedding Approach Uncovers LC-61, a Potent Anti-Leishmania infantum Compound.
Journal: Journal of chemical information and modeling
Published: March 17, 2026
Discovery of an efficacious 2-ethyl-4-phenylthiazole derivative against acute Chagas disease via multiparametric hit-to-lead optimization and in vivo efficacy.
Journal: European journal of medicinal chemistry
Published: March 09, 2026
Hit-To-Lead Optimization of a Pyridylpiperazine Class Against Malaria: Pharmacokinetic Profile and In Vivo Efficacy of Optimized Compounds.
Journal: ChemMedChem
Published: January 31, 2026
Design and Synthesis of Boronic Chalcones with Dual Anticancer and Anti-Inflammatory Activity.
Journal: Molecules (Basel, Switzerland)
Published: June 11, 2025
Discovery and Early Optimization of 1H-Indole-2-carboxamides with Anti-Trypanosoma cruzi Activity.
Journal: Journal of medicinal chemistry
Published: March 31, 2025
Isoindoline-1,3-dione Derivatives as Prototypes for Anticonvulsant Drug Discovery.
Journal: Medicinal chemistry (Shariqah (United Arab Emirates))
Published: August 01, 2024
Evaluation and discovery of novel benzothiazole derivatives as promising hits against Leishmania infantum.
Journal: Chemical biology & drug design
Published: January 20, 2024
Structure-activity relationships of novel N-imidazoylpiperazines with potent anti-Trypanosoma cruzi activity.
Journal: Future medicinal chemistry
Published: January 09, 2024
Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease.
Journal: European journal of medicinal chemistry
Published: September 25, 2022
Identification of natural cytochalasins as leads for neglected tropical diseases drug discovery.
Journal: PloS one
Published: June 10, 2022
Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents.
Journal: RSC medicinal chemistry
Published: June 04, 2021
Last Updated: 09/26/2026